APA (7th ed.) Citation

Amadori, S., & Ho, A. D. (2013). Sequential combination of gemtuzumab ozogamicin and standard chemotherapy in older patients with newly diagnosed acute myeloid leukemia: Results of a randomized phase III trial by the EORTC and GIMEMA consortium (AML-17). Journal of clinical oncology, 31(35), . https://doi.org/10.1200/JCO.2013.49.0771

Chicago Style (17th ed.) Citation

Amadori, Sergio, and Anthony Dick Ho. "Sequential Combination of Gemtuzumab Ozogamicin and Standard Chemotherapy in Older Patients with Newly Diagnosed Acute Myeloid Leukemia: Results of a Randomized Phase III Trial by the EORTC and GIMEMA Consortium (AML-17)." Journal of Clinical Oncology 31, no. 35 (2013). https://doi.org/10.1200/JCO.2013.49.0771.

MLA (9th ed.) Citation

Amadori, Sergio, and Anthony Dick Ho. "Sequential Combination of Gemtuzumab Ozogamicin and Standard Chemotherapy in Older Patients with Newly Diagnosed Acute Myeloid Leukemia: Results of a Randomized Phase III Trial by the EORTC and GIMEMA Consortium (AML-17)." Journal of Clinical Oncology, vol. 31, no. 35, 2013, https://doi.org/10.1200/JCO.2013.49.0771.